Shares of Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV – Get Free Report) were up 6.4% during trading on Wednesday . The company traded as high as $0.6948 and last traded at $0.6948. Approximately 1,246 shares changed hands during trading, an increase of 261% from the average daily volume of 345 shares. The stock had previously closed at $0.6533.
Mosaic ImmunoEngineering Price Performance
The firm has a market cap of $5.03 million, a PE ratio of -6.95 and a beta of -0.68. The business’s 50 day moving average price is $0.65 and its 200 day moving average price is $0.59.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last released its earnings results on Wednesday, April 15th. The company reported ($0.03) EPS for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.
Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.
Further Reading
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
